Supernus Pharmaceuticals Inc (SUPN) — Financial Flexibility Index
Supernus Pharmaceuticals Inc (SUPN) has a Financial Flexibility Index of 0.16x as of March 2026. Free cash flow of $66.52 Million (operating CF $66.52 Million minus capex $0.00) represents 0% of total liabilities ($423.92 Million). Check SUPN capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Supernus Pharmaceuticals Inc Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Supernus Pharmaceuticals Inc across 18 annual periods. See SUPN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Supernus Pharmaceuticals Inc (2008–2025)
Year-by-year free cash flow to debt coverage for Supernus Pharmaceuticals Inc. For the full company profile including market capitalisation, see Supernus Pharmaceuticals Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | $48.67 Million | $47.33 Million | $390.93 Million | ▼ -76.0% |
| 2024 | 0.52x | $172.68 Million | $171.95 Million | $332.34 Million | ▲ +65.8% |
| 2023 | 0.31x | $111.64 Million | $111.08 Million | $356.16 Million | ▲ +118.2% |
| 2022 | 0.14x | $117.24 Million | $116.83 Million | $816.30 Million | ▼ -2.9% |
| 2021 | 0.15x | $129.17 Million | $127.13 Million | $873.30 Million | ▼ -20.8% |
| 2020 | 0.19x | $141.85 Million | $138.40 Million | $759.24 Million | ▼ -27.7% |
| 2019 | 0.26x | $145.87 Million | $143.13 Million | $564.85 Million | ▲ +4.4% |
| 2018 | 0.25x | $129.83 Million | $128.99 Million | $524.79 Million | ▼ -66.7% |
| 2017 | 0.74x | $116.67 Million | $114.64 Million | $156.98 Million | ▲ +28.0% |
| 2016 | 0.58x | $68.42 Million | $66.81 Million | $117.81 Million | ▲ +18.5% |
| 2015 | 0.49x | $34.23 Million | $32.12 Million | $69.86 Million | ▲ +289.3% |
| 2014 | 0.13x | $8.33 Million | $7.73 Million | $66.15 Million | ▲ +117.6% |
| 2013 | -0.72x | $-55.60 Million | $-57.95 Million | $77.53 Million | ▲ +43.8% |
| 2012 | -1.28x | $-46.45 Million | $-47.20 Million | $36.42 Million | ▼ -59.1% |
| 2011 | -0.80x | $-35.50 Million | $-36.19 Million | $44.29 Million | ▼ -127.0% |
| 2010 | -0.35x | $-32.25 Million | $-32.54 Million | $91.33 Million | ▼ -1007.6% |
| 2009 | 0.04x | $3.35 Million | $2.63 Million | $86.06 Million | ▲ +111.1% |
| 2008 | -0.35x | $-29.52 Million | $-29.65 Million | $83.88 Million | — |